In contrast, ChRCC was frequent in patients at a relatively young age at diagnosis (P = 2.20E-03) and in those with aldehyde dehydrogenase 2 (ALDH2) dysfunction (rs671) (P = 1.11E-02). This evidence concerns the gene ALDH2 and chromophobe renal cell carcinoma.